INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,590,662 | -87.5% | 25,121 | -89.3% | 0.01% | -87.2% |
Q1 2023 | $12,678,085 | +23.4% | 234,129 | +20.6% | 0.04% | +11.4% |
Q4 2022 | $10,274,524 | -66.3% | 194,152 | -70.4% | 0.04% | -71.3% |
Q3 2022 | $30,514,000 | +114.0% | 655,800 | +18.0% | 0.12% | +67.1% |
Q3 2020 | $14,258,000 | +240.9% | 555,643 | -0.8% | 0.07% | +180.8% |
Q3 2019 | $4,182,000 | +243.3% | 559,900 | +459.9% | 0.03% | +333.3% |
Q1 2019 | $1,218,000 | -64.4% | 100,000 | -66.7% | 0.01% | -64.7% |
Q4 2018 | $3,421,000 | -75.2% | 300,352 | -52.7% | 0.02% | -70.2% |
Q3 2018 | $13,768,000 | +310.4% | 634,466 | +234.2% | 0.06% | +338.5% |
Q2 2018 | $3,355,000 | -30.9% | 189,857 | -17.6% | 0.01% | -35.0% |
Q1 2018 | $4,852,000 | -25.5% | 230,494 | -48.8% | 0.02% | -28.6% |
Q4 2017 | $6,516,000 | +58.4% | 450,000 | +72.6% | 0.03% | +55.6% |
Q3 2017 | $4,114,000 | +76.1% | 260,700 | +70.1% | 0.02% | +12.5% |
Q3 2016 | $2,336,000 | -64.5% | 153,300 | -9.5% | 0.02% | -64.4% |
Q2 2016 | $6,572,000 | +2.5% | 169,300 | -26.6% | 0.04% | -8.2% |
Q1 2016 | $6,411,000 | -27.4% | 230,600 | +40.4% | 0.05% | -32.9% |
Q4 2015 | $8,832,000 | +807.7% | 164,200 | +575.7% | 0.07% | +812.5% |
Q3 2015 | $973,000 | -73.3% | 24,300 | -78.7% | 0.01% | -68.0% |
Q2 2015 | $3,645,000 | +69.9% | 114,100 | +27.0% | 0.02% | +66.7% |
Q1 2015 | $2,145,000 | – | 89,823 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |